Expertise in
3
conditions

Bengt G. Glimelius

Uppsala, C, SE 
Expertise in
3
conditions
Uppsala, C, SE 

Overview

Bengt Glimelius practices practicing medicine in Uppsala, Sweden.

Mr. Glimelius is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Hodgkin Lymphoma, and Pancreatic Ductal Adenocarcinoma.

He is actively involved in clinical research, co-authoring 324 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Uppsala, C, Sweden
Other Locations
Karolinska Institutet
Stockholm, AB 17176, Sweden
Solna, AB 17176, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II Trial
Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II Trial
Enrollment Status: Completed
Publish Date: October 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Enrollment Status: Unknown
Publish Date: January 09, 2019
View 1 Less Clinical Trial

324 Total Publications

Treatment of localized rectal cancer in the Nordic countries-comparison of Nordic to Dutch, ESMO, and NCCN guidelines.
Treatment of localized rectal cancer in the Nordic countries-comparison of Nordic to Dutch, ESMO, and NCCN guidelines.
Journal: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society
Published: July 20, 2026

Frequently Asked Questions about Bengt G. Glimelius

Is Bengt G. Glimelius a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Bengt G. Glimelius is classified as an Elite expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bengt G. Glimelius participate in research or clinical trials?

Yes. Bengt G. Glimelius has published 324 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Bengt G. Glimelius's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Glimelius's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile